|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.95 EUR | -0.99% |
|
-3.50% | +10.07% |
| 20/07 | MERCK KGAA : UBS remains its Buy rating | ZD |
| 16/07 | Merck Opens BioReliance Testing Facility in Darmstadt Germany | CI |
Insider Transaction History
Latest insider transactions for Merck KGaA
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 25/03/26 | Buy | Chief Executive Officer | 3,386 | 103.53 | 4L | 0.0026% | ||
| 25/03/26 | Buy | Chief Financial Officer | 4,563 | 103.53 | 5L | 0.0035% | ||
| 27/03/25 | Buy | Chief Executive Officer | 2,341 | 130.61 | 3L | 0.0018% | ||
| 27/03/25 | Buy | Executive/Senior Manager | 4,507 | 130.61 | 6L | 0.0035% | ||
| 27/03/25 | Buy | 1,401 | 130.61 | 2L | 0.0011% | |||
| 27/03/25 | Buy | Executive/Senior Manager | 4,507 | 130.61 | 6L | 0.0035% | ||
| 27/03/24 | Buy | Executive/Senior Manager | 3,884 | 159.24 | 6L | 0.0030% | ||
| 27/03/24 | Buy | Executive/Senior Manager | 3,884 | 159.24 | 6L | 0.0030% | ||
| 29/03/23 | Buy | Executive/Senior Manager | 1,684 | 172.63 | 3L | 0.0013% | ||
| 29/03/23 | Buy | Chief Executive Officer | 636 | 172.63 | 1L | 0.0005% | ||
| 13/05/22 | Buy | Chief Executive Officer | 2,39,944 | 159.96 | 3.84Cr | 0.1857% | ||
| 23/12/21 | Buy | Chief Executive Officer | 1,550 | 220.00 | 3L | 0.0012% | ||
| 24/09/21 | Buy | Chief Financial Officer | 1,000 | 199.32 | 2L | 0.0008% | ||
- Stock Market
- Stocks
- MRK Stock
- Company Merck KGaA
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















